human
bocaviru
hbov
dna
viru
classifi
parvovirida
famili
first
describ
alland
et
al
detect
hospit
children
respiratori
diseas
jartti
et
al
howev
also
found
children
mild
infect
martin
et
al
asymptomat
one
garc
et
al
hbov
infect
coinfect
one
virus
calvo
et
al
prolong
viral
shed
describ
day
outpati
martin
et
al
month
hospit
children
bless
et
al
probabl
explain
hbov
detect
asymptomat
case
von
linstow
et
al
although
pathogen
role
hbov
question
serolog
diagnosi
hbov
recent
confirm
signific
increas
igg
antibodi
children
pneumonia
result
support
idea
true
pathogen
respiratori
tract
infect
children
unfortun
techniqu
yet
avail
mani
laboratori
requir
invas
procedur
diagnosi
context
would
like
contribut
knowledg
hbov
infect
longterm
prospect
studi
aim
determin
incid
hbov
hospit
children
epidemiolog
profil
describ
main
clinic
featur
infect
children
also
compar
clinic
characterist
singl
hbov
infect
preval
singl
viral
infect
popul
attempt
differenti
characterist
infect
studi
popul
compris
children
first
month
life
year
age
respiratori
tract
diseas
admit
secondari
public
hospit
severo
ochoa
legan
es
madrid
septemb
august
studi
approv
medic
ethic
committe
prior
sampl
collect
inform
consent
obtain
parent
legal
guardian
patient
evalu
attend
physician
clinic
characterist
patient
analyz
hospit
stay
part
studi
physician
fill
studyquestionnair
clinic
data
upper
respiratori
tract
infect
urti
diagnos
patient
rhinorrhea
andor
cough
sign
wheez
dyspnea
crackl
bronchodil
use
without
fever
asthma
diagnos
basi
nation
asthma
educ
prevent
program
guidelin
naepp
episod
acut
expiratori
wheez
consid
recurr
wheez
acut
expiratori
wheez
consid
bronchiol
occur
first
time
children
age
less
year
laryngotracheobronch
associ
inspiratori
dyspnea
wheez
laryng
associ
inspiratori
dyspnea
without
wheez
case
focal
infiltr
consolid
chest
xray
absenc
wheez
classifi
pneumonia
clinic
specimen
consist
nasopharyng
aspir
npa
taken
patient
admiss
mondayfriday
clinic
specimen
sent
respiratori
viru
influenza
unit
nation
microbiolog
center
isciii
madrid
spain
virolog
investig
npa
process
within
hr
collect
upon
receipt
three
aliquot
prepar
store
three
rtnest
pcr
assay
perform
detect
total
respiratori
virus
assay
revers
transcript
rt
first
amplif
round
carri
singl
tube
use
qiagen
onestep
rtpcr
kit
qiagen
hilden
germani
influenza
b
c
virus
detect
use
previous
describ
primer
set
amplifi
influenza
virus
multiplex
pcr
assay
coira
et
al
second
multiplex
pcr
use
detect
parainfluenza
virus
human
coronavirus
enterovirus
rhinovirus
rv
coira
et
al
presenc
respiratori
syncyti
viru
rsv
b
type
human
metapneumoviru
hmpv
human
bocaviru
hbov
adenovirus
investig
third
multiplex
rtnest
pcrbrq
method
calvo
et
al
valu
express
percentag
discret
variabl
mean
standard
deviat
continu
variabl
clinic
characterist
patient
singl
infect
associ
hbov
compar
associ
coinfect
hbov
respiratori
virus
singl
hbov
infect
also
compar
singl
infect
rsv
rv
hmpv
clinic
characterist
laboratori
variabl
compar
use
student
ttest
mannwhitney
utest
x
test
fisher
exact
test
twosid
valu
p
consid
statist
signific
result
adjust
age
analys
perform
use
statist
packag
social
scienc
spss
version
total
case
respiratori
diseas
analyz
studi
period
one
virus
detect
sampl
multipl
infect
present
posit
case
frequent
identifi
viru
rsv
follow
rv
adenoviru
hadv
hbov
fourth
frequenc
detect
case
posit
case
figur
case
singl
detect
detect
coinfect
virus
mainli
rsv
rv
hadv
fig
circul
hbov
higher
autumn
case
novemb
decemb
clinic
characterist
patient
respiratori
episod
associ
singl
hbov
detect
analyz
tabl
group
mean
age
month
standard
deviat
month
fever
present
case
hypoxia
recurr
wheez
asthma
diagnos
case
follow
pneumonia
xray
infiltr
present
patient
clinic
case
associ
singl
hbov
detect
compar
case
hbov
coinfect
tabl
diagnosi
differ
group
case
singl
hbov
detect
diagnos
pneumonia
frequent
p
coinfect
one
patient
wheez
singl
hbov
detect
concomit
urinari
tract
infect
bacteremia
eight
patient
two
differ
admiss
studi
period
associ
hbov
tabl
ii
interv
clinic
episod
day
month
asymptomat
episod
perform
viral
determin
period
one
patient
two
differ
admiss
year
apart
singl
viral
infect
clinic
characterist
patient
singl
hbov
detect
compar
singl
infect
associ
rsv
rv
hmpv
period
hbov
versu
rsv
rsv
singl
infect
present
children
frequent
identifi
viru
observ
hbov
affect
male
vs
p
later
age
vs
month
p
associ
distinct
clinic
featur
episod
wheez
asthma
pneumonia
frequent
bronchiol
less
frequent
characterist
rsv
infect
p
hypoxia
vs
p
durat
hypoxia
day
stay
significantli
higher
rsv
infect
leukocyt
crp
significantli
higher
hbov
infect
also
proport
patient
treat
antibiot
vs
p
hbov
circul
fig
mainli
novemb
decemb
case
coincid
rsv
month
howev
rsv
also
frequent
identifi
januari
case
tabl
iii
hbov
versu
hmpv
hmpv
singl
infect
present
children
studi
period
group
compris
children
younger
hbovposit
children
vs
month
p
diagnosi
pneumonia
frequent
hbov
children
also
receiv
antibiot
vs
p
leukocyt
blood
crp
also
significantli
higher
hbov
group
nevertheless
hospit
longer
hmpv
group
p
hmpv
mainli
detect
spring
marchmay
fig
tabl
iv
hbov
versu
rv
rv
singl
infect
present
case
second
preval
viru
group
similar
age
proport
children
fever
higher
hbov
infect
vs
p
comparison
diagnosi
pneumonia
frequent
hbov
group
children
also
fever
frequent
receiv
antibiot
vs
p
differ
found
rv
circul
throughout
year
higher
incid
autumn
fig
tabl
v
hbov
experi
fourth
viru
identifi
respiratori
infect
hospit
children
howev
case
detect
singl
pathogen
remain
case
character
coinfect
singl
infect
character
presenc
high
fever
wheez
signific
percentag
pneumonia
hypoxia
moder
leukocytosi
elev
crp
lead
frequent
antibiot
treatment
children
averag
old
infect
occur
mainli
novemb
decemb
although
hbov
season
coincid
rsv
clinic
characterist
virus
quit
differ
rsv
affect
younger
children
caus
bronchiol
less
frequent
associ
radiograph
infiltr
induc
leukocytosi
crp
normal
hmpv
circul
spring
clinic
featur
similar
rsv
differ
hbov
infect
rhinoviru
circul
throughout
year
children
similar
age
hbov
group
also
wheez
infiltr
fever
less
frequent
data
suggest
hbov
infect
characterist
support
role
viru
actual
pathogen
although
author
martin
et
al
find
differenti
clinic
data
outpati
posit
hbov
seri
describ
set
characterist
clinic
data
hospit
children
differ
singl
infect
caus
virus
rsv
hmpv
potenti
explan
differenti
clinic
characterist
found
patient
might
lie
greater
sever
hospit
patient
versu
ambulatori
one
furthermor
number
patient
analyz
martin
could
make
difficult
find
distinguish
characterist
seri
includ
larg
number
patient
allow
us
draw
conclus
clinic
data
homogen
popul
although
studi
compar
clinic
characterist
hbov
infect
virus
author
moriyama
et
al
also
find
clear
differ
hbov
rsv
younger
age
bronchiol
hypoxia
frequent
rsv
group
case
seri
found
specif
comparison
hbov
rv
hmpv
except
previou
work
group
calvo
et
al
studi
zhang
china
small
group
differ
virus
zhang
et
al
could
find
characterist
data
hbov
infect
mani
studi
confirm
rel
high
frequenc
hbov
infect
hospit
children
associ
wheez
episod
amar
de
leon
et
al
pneumonia
esposito
et
al
wang
et
al
coinfect
frequent
also
previou
studi
calvo
et
al
fri
et
al
martin
et
al
broccolo
et
al
might
suggest
symptom
may
caus
virus
addit
hbov
abl
persist
therefor
could
often
detect
accompani
pathogen
sever
author
demonstr
hbov
persist
differ
cell
usebrink
et
al
intestin
tissu
kapoor
et
al
lung
tumor
schildgen
et
al
tonsillar
tissu
children
falcon
et
al
moreov
byington
et
al
detect
persist
hbov
children
without
symptom
last
longer
virus
therefor
posit
hbov
impli
causal
storch
furthermor
worth
mention
huang
et
al
dijkman
et
al
shown
hbov
induc
cytopath
effect
human
airway
epitheli
cell
cultur
unlik
harmless
bystand
would
abl
produc
cytopath
effect
prolong
hbov
shed
found
martin
other
bless
et
al
could
also
caus
detect
coinfect
virus
presenc
asymptomat
children
recent
outpati
popul
martin
et
al
found
children
infect
hbov
like
experi
recurr
cough
episod
visit
healthcar
provid
day
follow
time
initi
detect
hbov
sequenc
sampl
children
posit
ident
therefor
consid
hbov
reinfect
contribut
longterm
shed
although
hbov
sequenc
determin
patient
two
fact
could
help
explain
recurr
infect
found
percentag
patient
seri
one
admiss
hbov
posit
detect
short
period
time
although
might
expect
viral
load
could
differ
acut
infect
asymptomat
elimin
quantif
viral
load
help
differenti
symptomat
asymptomat
infect
opinion
might
happen
techniqu
viral
load
measur
appropri
respiratori
secret
standard
sampl
difficult
might
also
explain
conflict
result
differ
studi
martin
et
al
ghietto
et
al
principi
et
al
although
specif
includ
studi
fail
find
differ
viral
load
symptomat
asymptomat
patient
still
sever
infect
might
correl
viral
load
studi
moesker
et
al
report
higher
viral
load
hbovposit
patient
admit
intens
care
unit
studi
strength
prospect
natur
long
studi
period
number
patient
studi
singl
multipl
detect
comparison
preval
virus
also
limit
sinc
control
group
howev
confirm
previou
work
group
symptomat
children
set
significantli
higher
hbov
posit
healthi
children
garc
et
al
serial
sampl
collect
assess
shed
hbov
prevent
us
know
recurr
case
neg
sampl
episod
serolog
therefor
confirm
infect
acut
hbov
causal
agent
serolog
demonstr
hbov
pathogen
role
respiratori
infect
kantola
et
al
oderlundvenermo
et
al
et
al
avail
last
year
laboratori
remark
studi
et
al
serolog
confirm
pathogen
role
hbov
children
pneumonia
one
frequent
diagnos
found
seri
studi
ghietto
et
al
match
seri
find
clinic
differ
singl
infect
coinfect
hbov
may
also
suggest
role
viru
multipl
infect
summari
present
long
prospect
studi
respiratori
hbov
infect
consider
number
patient
compar
viral
infect
clinic
featur
specif
viru
shown
futur
prospect
studi
probabl
includ
serolog
studi
shed
viru
may
help
clarifi
remain
doubt
hbov
infect
children
